Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Enfusion (ENFN)
NYSE:ENFN
Enfusion (ENFN) Stock Price & Analysis
19 Followers
ENFN Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$7.37 - $11.56
Previous Close$9.57
Volume255.94K
Average Volume (3M)417.19K
Market Cap
$1.23B
Enterprise Value$1.23B
Total Cash (Recent Filing)$35.60M
Total Debt (Recent Filing)$15.44M
Price to Earnings (P/E)197.7
Beta1.34
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.05
Shares Outstanding128,069,912
10 Day Avg. Volume289,860
30 Day Avg. Volume417,185
Standard Deviation0.17
R-Squared0.09
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)22.72
Price to Sales (P/S)4.93
Price to Cash Flow (P/CF)46.30
P/FCF Ratio83.20
Enterprise Value/Market CapN/A
Enterprise Value/Revenue7.30
Enterprise Value/Gross Profit7.06
Enterprise Value/Ebitda92.70
Forecast
1Y Price Target
$10.50Price Target Upside9.72% Upside
Rating ConsensusHold
Number of Analyst Covering6
Enfusion News
PremiumCompany Announcements
Enfusion’s Upcoming Investor Day and Information Disclosure
Bulls Say, Bears Say
Bulls Say
Financial ForecastEnfusion anticipates significant revenue growth coupled with an increase in EBITDA margin and Free Cash Flow conversion, reflecting a robust financial outlook.
Market OpportunityManagement has identified a substantial Total Addressable Market, suggesting Enfusion is poised for considerable growth as it modernizes portfolio management for asset managers.
Product DevelopmentThe launch of Portfolio Workbench marks a key milestone for Enfusion, enhancing mid-market penetration and expanding their Decision Analytics services.
Bears Say
Financial PerformanceRevenue projections by the Street are seen as overly optimistic compared to the analyst's more conservative estimates.
Growth ConcernsThe stock maintains a Sell rating as it may take time for Enfusion to realize a higher normalized growth and margin profile.
Investor SentimentDespite good 4Q23 results, consistent results over additional quarters are likely needed to significantly improve investor sentiment.
---
Ownership Overview
67.58% Insiders
16.97% Mutual Funds
6.88% Other Institutional Investors
8.57% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ENFN FAQ
What was Enfusion’s price range in the past 12 months?
Enfusion lowest stock price was $7.37 and its highest was $11.56 in the past 12 months.
What is Enfusion’s market cap?
Currently, no data Available
When is Enfusion’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Enfusion’s earnings last quarter?
Currently, no data Available
Is Enfusion overvalued?
According to Wall Street analysts Enfusion’s price is currently Undervalued.
Does Enfusion pay dividends?
Enfusion does not currently pay dividends.
What is Enfusion’s EPS estimate?
Enfusion’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Enfusion have?
Enfusion has 89,871,150 shares outstanding.
What happened to Enfusion’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Enfusion?
Among the largest hedge funds holding Enfusion’s share is Gilder Gagnon Howe & Co LLC.. It holds Enfusion’s shares valued at 413K.
---
Enfusion Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$10.50 (9.72% Upside)
$10.50 (9.72% Upside)
Blogger Sentiment
Bullish
ENFN Sentiment 100%
Sector Average 68%
Sector Average 68%
Hedge Fund Trend
Decreased
By 52.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.2K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
13.92%
12-Months-Change
Fundamentals
Return on Equity
10.18%
Trailing 12-Months
Asset Growth
-11.97%
Trailing 12-Months
Company Description
Enfusion
Enfusion Inc is a software-as-a-service (SaaS) provider focused on transforming the investment management industry. Its solutions are designed to eliminate technology and information barriers, empowering investment managers to make and execute better-informed investment decisions in real-time. It simplifies investment and operational workflows by unifying mission-critical systems and coalescing data into a single dataset resulting in a single source of truth.
---
ENFN Stock 12 Month Forecast
Average Price Target
$10.50
▲(9.72% Upside)
Technical Analysis
Best Analysts Covering ENFN
1 Year
1 Year Success Rate
3/6 ratings generated profit
1 Year Average Return
-6.97%
reiterated a buy rating 2 months ago
Copying J. Parker Lane's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of -6.97% per trade.
---